Cabaletta Bio, Inc. (CABA)
2.00
+0.11
(+5.82%)
USD |
NASDAQ |
Oct 02, 16:00
2.00
0.00 (0.00%)
After-Hours: 06:59
Cabaletta Bio Price to Book Value : 1.593 for Oct. 2, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 02, 2026 | 1.593 |
| October 01, 2026 | 1.505 |
| September 30, 2026 | 1.529 |
| September 29, 2026 | 1.577 |
| September 28, 2026 | 1.593 |
| September 25, 2026 | 1.649 |
| September 24, 2026 | 1.716 |
| September 23, 2026 | 1.768 |
| September 22, 2026 | 1.991 |
| September 21, 2026 | 1.959 |
| September 18, 2026 | 2.031 |
| September 17, 2026 | 2.055 |
| September 16, 2026 | 1.983 |
| September 15, 2026 | 2.067 |
| September 14, 2026 | 2.318 |
| September 11, 2026 | 2.174 |
| September 10, 2026 | 2.182 |
| September 09, 2026 | 2.318 |
| September 08, 2026 | 2.604 |
| September 04, 2026 | 2.764 |
| September 03, 2026 | 2.772 |
| September 02, 2026 | 2.843 |
| September 01, 2026 | 2.628 |
| August 31, 2026 | 2.477 |
| August 28, 2026 | 2.485 |
| Date | Value |
|---|---|
| August 27, 2026 | 2.692 |
| August 26, 2026 | 2.588 |
| August 25, 2026 | 2.565 |
| August 24, 2026 | 2.469 |
| August 21, 2026 | 2.493 |
| August 20, 2026 | 2.541 |
| August 19, 2026 | 2.469 |
| August 18, 2026 | 2.318 |
| August 17, 2026 | 2.302 |
| August 14, 2026 | 2.190 |
| August 13, 2026 | 2.158 |
| August 12, 2026 | 2.270 |
| August 11, 2026 | 2.222 |
| August 10, 2026 | 2.230 |
| August 07, 2026 | 2.222 |
| August 06, 2026 | 2.198 |
| August 05, 2026 | 2.158 |
| August 04, 2026 | 2.206 |
| August 03, 2026 | 2.142 |
| July 31, 2026 | 2.134 |
| July 30, 2026 | 2.166 |
| July 29, 2026 | 2.087 |
| July 28, 2026 | 2.174 |
| July 27, 2026 | 2.166 |
| July 24, 2026 | 2.142 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Agenus, Inc. | -- |
| Amgen, Inc. | 18.64 |
| BioCryst Pharmaceuticals, Inc. | -- |
| Imunon, Inc. | 1.426 |
| Curis, Inc. | 0.3335 |
Price to Book Value Related Metrics
| Price | 2.00 |
| Earnings Yield | -79.09% |
| Market Cap | 335.45M |